CDKN1A and non-small cell lung carcinoma: For example, overexpression of HER-2 leads to the cyclin-dependent kinase inhibitor 1A nuclear exclusion which contributes to cisplatin resistance [4] and it has been related to cisplatin resistance in NSCLC patients [31].